Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease

American Journal of Gastroenterology

Volumn 94, Issue 6, 1999, Pages 1434-1442

  Devault, Kenneth R ^a   Castell, Donald O ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACID; ALGINIC ACID; ANTACID AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CIMETIDINE; CISAPRIDE; DOMPERIDONE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE;

ATROPHIC GASTRITIS; BARRETT ESOPHAGUS; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC BIOPSY; ESOPHAGITIS; ESOPHAGUS MANOMETRY; GASTROESOPHAGEAL REFLUX; HEART ARRHYTHMIA; HUMAN; LIFESTYLE; LONG TERM CARE; MAINTENANCE THERAPY; META ANALYSIS; NEUROTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STOMACH ACID; SYMPTOMATOLOGY;

GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; HUMANS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 0032976315     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.1123_a.x     Document Type: Review

References (118)

1. DeVault K.R., Castell D.O. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med. 155:1995;2165-2173.
2. Klauser A.G., Schindbeck N.E., Muller-Lissner S.A. Symptoms in gastro-oesophageal reflux disease. Lancet. 335:1990;205-208.
3. Tefera L., Fein M., Ritter M.P., et al. Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease? Am Surg. 63:1997;933-936.
4. Katzka D.A., Paoletti V., Leite L., et al. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms Testing while on therapy identifies the need for more aggressive antireflux therapy . Am J Gastroenterol. 91:1996;2110-2113.
5. Sampliner R.E. Practice guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol. 93:1998;1028-1032.
6. Johnson D.A., Winters C., Spurling T.J., et al. Esophageal acid sensitivity in Barrett's esophagus. J Clin Gastroenterol. 9:1987;23-27.
7. Vincent M.E., Robbins A.H., Spechler S.J., et al. The reticular pattern as a radiographic sign of Barrett's esophagus An assessment . Radiology. 153:1984;333-335.
8. Koehler R.E., Weymean P.J., Oakley H.F. Single- and double-contrast techniques in esophagitis. AJR. 135:1980;15-19.
9. Ott D.J., Chen Y.M., Gelfand D.W., et al. Analysis of a multiphasic radiographic examination for detecting reflux esophagitis. Gastrointest Radiol. 11:1986;1-6.
10. Creteur V., Thoeni R.F., Federle M.P., et al. The role of single- and double-contrast radiography in the diagnosis of reflux esophagitis. Radiology. 147:1983;71-75.
11. Ott D.J., Wu W.C., Gelfand D.W. Reflux esophagitis revisited Prospective analysis of radiological accuracy . Gastrointest Radiol. 6:1981;1-7.
12. Sellar R.J., DeCaestecker J.S., Heading R.C. Barium radiology A sensitive test for gastro-oesophageal reflux . Clin Radiol. 38:1987;303-307.
13. Ott D.J., Gelfand D.W., Wu W.C. Reflux esophagitis Radiologic and endoscopic correlation . Radiology. 103:1979;583-588.
14. Johnston B.T., Troshinsky M.B., Castell J.A., et al. Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease. Am J Gastroenterol. 91:1996;1181-1185.
15. Johnston B.T., Nunn S., Sloan J.M., et al. The application of microridge analysis in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol. 31:1996;97-102.
16. Schindbeck N.E., Wiebecke B., Klauser A.G., et al. Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut. 39:1996;151-154.
17. Pace F., Santalucia F., Bianchi P.G. Natural history of gastroesophageal reflux disease without esophagitis. Gut. 32:1991;845-848.
18. Trimble K.C., Douglas S., Pryde A., et al. Clinical characteristics and natural history of symptomatic but not excessive gastroesophageal reflux. Dig Dis Sci. 40:1995;1098-1104.
19. Watson R.G., Tham T.C., Johnston B.T., et al. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux - The sensitive esophagus. Gut. 40:1997;587-590.
20. Tew S., Jamieson G.G., Pilowski I., et al. The illness behavior of patients with gastroesophageal reflux disease with and without endoscopic esophagitis. Dis Esophagus. 10:1997;9-15.
21. Mattox H.E., Richter J.E. Prolonged ambulatory esophageal pH monitoring in the evaluation of gastroesophageal reflux disease. Am J Med. 89:1990;345-356.
22. Weiner G.J., Morgan T.M., Copper J.B., et al. Ambulatory 24 hour esophageal pH monitoring Reproducibility and variability of pH parameters . Dig Dis Sci. 33:1988;1127-1133.
23. Schlesinger P.K., Donahue P.E., Schmidt B., et al. Limitations of 24 hour intraesophageal pH monitoring in the hospital setting. Gastroenterology. 89:1985;797-804.
24. Murphy D.W., Yuan Y., Castell D.O. Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans. Dig Dis Sci. 34:1989;649-656.
25. Klinkenberg-Knol E.C., Meuwissen S.G. Combined gastric and oesophageal pH-metry in patients with reflux disease, resistant to omeprazole. Aliment Pharmacol Therap. 4:1990;485-489.
26. Richter J.E. Provocative tests in esophageal disease. Scarpignato C., Galmiche J.P. Functional evaluation in esophageal disease. Frontiers of gastrointestinal research. Vol. 22:1994;188 Karger, Basel.
27. Johnsson F., Weywadt L., Sonhaug J.N., et al. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol. 33:1998;15-20.
28. Schenk B.E., Kuipers E.J., Klinkenberg-Knol E.C., et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol. 92:1997;1997-2000.
29. Wo J.M., Grist W.J., Gussack G., et al. Empiric trial of high-dose omeprazole in patients with posterior laryngitis A prospective study . Am J Gastroenterol. 92:1997;2160-2165.
30. Fass R., Fennerty M.B., Ofman J.J., et al. The clinical and economic value of omeprazole in patients with noncardiac chest pain. Gastroenterology. 115:1998;42-49.
31. Klauser A.G., Schindbeck N.E., Muller-Lissner S.A. Esophageal 24-h pH monitoring Is prior manometry necessary for correct positioning of the electrode? Am J Gastroenterol. 85:1990;1463-1467.
32. Mattox H.E., Richter J.E., Sinclair J.W., et al. The gastroesophageal pH step-up inaccurately locates the proximal border of the lower esophageal sphincter. Dig Dis Sci. 37:1992;1185-1191.
33. DeVault K.R., Castell D.O. A simplified technique for accurate placement of ambulatory pH probes. Am J Gastroenterol. 86:1991;380-381.
34. Singh S., Price J.E., Richter J.E. The LES locator Accurate placement of an electrode for 24-hour pH measurement with a combined solid state pressure transducer . Am J Gastroenterol. 87:1992;967-970.
35. Patti M.G., Arcerito M., Pelligrini C.A., et al. Minimally invasive surgery for gastroesophageal reflux disease. Am J Surg. 170:1995;614-617.
36. Kauer W.K., Peters J.H., DeMeester T.R., et al. A tailored approach to antireflux surgery. J Thorac Cardiovasc Surg. 110:1995;141-146.
37. Waring J.P., Hunter J.G., Oddosdottir M., et al. The preoperative evaluation of patients considered for laparoscopic antireflux surgery. Am J Gastroenterol. 90:1995;35-38.
38. Patti M.G., De Bellis M., De Pinto M., et al. Partial fundoplication for gastroesophageal reflux. Surg Endosc. 11:1997;445-448.
39. Leite L.P., Johnston B.T., Barrett J., et al. Ineffective esophageal motility (IEM) The primary finding in patients with nonspecific esophageal motility disorder . Dig Dis Sci. 42:1997;1859-1865.
40. Stanciu C., Bennett J.R. Effects of posture on gastro-oesophageal reflux. Digestion. 15:1977;104-109.
41. Johnson L.F., DeMeester T.R. Evaluation of elevation of the head of the bed, bethanechol, and antacid foam tablets on gastroesophageal reflux. Dig Dis Sci. 26:1981;673-680.
42. Becker D.J., Sinclair J., Castell D.O., et al. A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol. 84:1989;782-786.
43. Waring J.P., Eastwood T.F., Austin J.M., et al. The immediate effects of cessation of cigarette smoking on gastroesophageal reflux. Am J Gastroenterol. 84:1989;1076-1078.
44. Meyers W.F., Herbst J.J. Effectiveness of positioning therapy for gastroesophageal reflux. Pediatrics. 69:1982;768-772.
45. Murphy D.W., Castell D.O. Chocolate and heartburn Evidence of increased esophageal acid exposure after chocolate ingestion . Am J Gastroenterol. 83:1988;633-636.
46. Pehl C., Wendl B., Pfeiffer A., et al. Low-proof alcoholic beverages and gastroesophageal reflux. Dig Dis Sci. 38:1993;93-96.
47. Sigmund C.J., McNally E.F. The action of a carminative on the lower esophageal sphincter. Gastroenterology. 56:1969;13-18.
48. Wendl B., Pfeiffer A., Pehl C., et al. Effect of decaffeination of coffee or tea on gastro-oesophageal reflux. Aliment Pharmacol Ther. 8:1994;283-287.
49. Allen M.L., Mellow M.H., Robinson M.G., et al. The effect of raw onions on acid reflux and reflux symptoms. Am J Gastroenterol. 85:1990;377-380.
50. Beauchamp G. Gastroesophageal reflux and obesity. Surg Clin North Am. 63:1983;869-876.
51. Saco L.S., Orlando R.C., Levinson S.L., et al. Double-blind controlled trial of bethanecol and antacid versus placebo and antacid in the treatment of erosive esophagitis. Gastroenterology. 82:1982;1369-1373.
52. Graham D.Y., Patterson D.J. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis. Dig Dis Sci. 28:1983;559-563.
53. Buts J.P., Barudi C., Otte J.B. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24H continuous pH monitoring in infants and children. Eur J Pediatr. 146:1987;156-158.
54. Castell D.O., Dalton C.B., Becker D., et al. Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal strength anacid. Dig Dis Sci. 37:1992;589-593.
55. Stanciu C., Bennett J.R. Alginate/antacid in the reduction of gastroesophageal reflux. Lancet. 1:1974;109-111.
56. Lieberman D.A. Medical therapy for chronic reflux esophagitis. Long term follow-up. Arch Intern Med. 147:1987;717-720.
57. Behar J., Sheahan D.G., Biancani P., et al. Medical and surgical management of reflux esophagitis A 38-month report on a prospective clinical trial . N Engl J Med. 293:1975;263-268.
58. Mann S.G., Murakami A., McCarroll K., et al. Low dose famotidine in the prevention of sleep disturbance caused by heartburn after an evening meal. Aliment Pharmacol Ther. 9:1995;395-401.
59. Behar J., Brand D.L., Brown F.C., et al. Cimetidine in the treatment of symptomatic gastroesophageal reflux. Gastroenterology. 74:1978;441-448.
60. Sontag S., Robinson M., McCallum R.W., et al. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial. Arch Intern Med. 147:1987;1485-1491.
61. Euler A.R., Murdock R.H., Wilson T.H., et al. Ranitidine is effective therapy for erosive esophagitis. Am J Gastroenterol. 88:1993;520-524.
62. Klinkenburg-Kriol E.C., Festen H.P., Jansen J.B., et al. Long-term treatment with omeprazole for refractory reflux esophagitis Efficacy and safety . Ann Intern Med. 121:1994;161-167.
63. Jansen J.B., Klinkenberg-Knol E.C., Meuwissen S.G., et al. Effect of long-term treatment with omeprazole on serum gastric and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology. 99:1990;621-628.
64. Kuipers E.J., Lundell L., Klinkenberg-Knol E.C., et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 334:1996;1018-1022.
65. Howden C.W., Hunt R.H. Guidelines for the management of Helicobacter pylori infection. Am J Gastroenterology. 93:1998;2330-2338.
66. Schenk B.E., Festen H.P., Kuipers E.J., et al. Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin. Aliment Pharmacol Therap. 10:1996;541-545.
67. Hutchinson S., Logan R. The effect of long-term omeprazole on the glucose-hydrogen breath test in elderly patients. Age Aging. 26:1997;87-89.
68. Eggleston A., Wigerinck A., Huijghebaert S., et al. Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice A clinical database analysis . Gut. 42:1998;13-16.
69. Hillman A.L., Bloom B.S., Fendrick A.M., et al. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. Arch Intern Med. 152:1992;1467-1472.
70. Castell D.O. Gastroesophageal reflux disease is a motility disorder. Scarignato C. Advances in drug therapy of gastroesophageal reflux disease. 1992;11-16 Karger, Basel.
71. Ganzini L., Casey D.E., Hofman W.F., et al. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med. 153:1993;1469-1475.
72. Galmiche J.P., Fraitag B., Filoche B., et al. Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis. Dig Dis Sci. 35:1990;649-655.
73. Lepoutre L., Van der Spek P., Vanderlinden I., et al. Healing of grade-II and III oesophagitis through motility stimulation with cisapride. Digestion. 45:1990;109-114.
74. Richter J.E., Long J.F. Cisapride for gastroesophageal reflux disease A placebo-controlled, double-blind study . Am J Gastroenterol. 90:1995;423-430.
75. Lieberman D.A., Keefe E.B. Treatment of severe reflux esophagitis with cimetidine and metoclopramide. Ann Intern Med. 104:1986;21-26.
76. Galmiche J.P., Brandstatter G., Evreux M., et al. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis A double blind placebo-controlled trial . Gut. 29:1988;675-681.
77. Toussaint J., Gossuin A., Deruyttere M., et al. Healing and prevention of relapse of reflux oesophagitis by cisapride. Gut. 32:1991;1280-1285.
78. Blum A.L., Adami B., Bouzo M.N., et al. Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. Dig Dis Sci. 38:1993;551-560.
79. Vigneri S., Termini R., Leandro G., et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med. 333:1995;1106-1110.
80. Holloway R.H., Downton J., Mitchell B., et al. Effect of cisapride on postprandial gastro-oesophageal reflux. Gut. 30:1989;1187-1193.
81. Chan-Tompkins N.H., Babinchak T.J. Cardiac arrhythimas associated with coadministration of azole compounds and cisapride. Clin Infect Dis. 24:1997;1285.
82. Rampe D., Roy M.L., Dennis A., et al. A mechanism for the proarrhythmic effects of cisapride (Propulsid) High affinity blockade of the human cardiac potassium channel HERG . FEBS Lett. 417:1997;28-32.
83. Antonson C.W., Robinson M.G., Hawkins T.M., et al. High doses of histamine antagonists do not prevent relapses of peptic esophagitis following therapy with a proton pump inhibitor. Gastroenterology. 98:1990;A16.
84. Bank S., Greenberg R. Alternate day omeprazole in H2 receptor-antagonist resistant reflux esophagitis. Gastroenterology. 100:1991;A29.
85. Dent J., Yeomans N.D., Mackinnon M., et al. Omeprazole v randitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Gut. 35:1994;590-598.
86. Hallerback B., Unge P., Carling L., et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology. 107:1994;1305-1311.
87. Sandmark S., Carlsson R., Fausa O., et al. Omeprazole or ranitidine in the short-term treatment of ulcerative reflux oesophagitis. Results of a double-blind randomized Scandinavian multicenter study. Scand J Gastroenterol. 23:1988;625-632.
88. Ferguson R., Dronfield M.W., Atkinson M. Cimetidine in treatment of reflux oesophagitis with peptic stricture. Br Med J. 2:1979;472-474.
89. Marks R.D., Richter J.E., Rizzo J., et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology. 106:1994;907-915.
90. Gough A.L., Long R.G., Cooper B.T., et al. Lansaprazole versus ranitidine in the maintenance treatment of reflux oesophagitis. Aliment Pharmacol Ther. 10:1996;529-539.
91. Klinkenberg-Knol E.C., Festen H.P.M., Jansen J.B.M.J., et al. Long-term treatment with omeprazole for refractory reflux esophagitis Efficacy and safety . Ann Intern Med. 121:1994;161-167.
92. Kim S.L., Waring J.P., Spechler S.J., et al. Effects of antireflux therapy on the extent of Barrett's epithelium. Gastroenterology. 104:1993;A118.
93. Neumann C.S., Iqbal T.H., Cooper B.T. Long term continuous omeprazole treatment of patients with Barrett's oesophagus. Aliment Pharmacol Ther. 9:1995;451-454.
94. Meshkinpour H. Esophageal aperistalsis and gastroesophageal reflux disorder. Am J Gastroenterol. 90:1995;910-914.
95. DeMeester T.R., Bonavina L., Albertucci M. Nissen fundoplication for gastroesophageal reflux disease. Ann Surg. 204:1986;9-20.
96. Spechler S.J. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Study Group. N Eng J Med. 326:1992;786-792.
97. Lundell L., Dalenvack J., Hattlevakk J., et al. Omeprazole or antireflux surgery in the long term management of gastroesophageal reflux disease Results of a multicentre, randomized, clinical trail . Gastroenterology. 114:1998;A207.
98. Lundell L.R., Meyer J.C., Jamieson C.G. Delayed gastric emptying and its relationship to symptoms of "gas bloat" after antireflux surgery. Eur J Surg. 160:1994;161-166.
99. Little A.G., Martinez E.I., DeMeester T.R., et al. Duodenogastric reflux and reflux esophagitis. Surgery. 96:1984;447-454.
100. Champion G., Richter J.E., Vaezi M.F., et al. Duodenogastroesophageal reflux Relationship to pH and importance in Barrett's esophagus . Gastroenterology. 107:1994;747-754.
101. Sears R.J., Champion G.L., Richter J.E. Characteristics of distal partial gastrectomy patients with esophageal symptoms of duodenogastric reflux. Am J Gastroenterol. 90:1995;211-215.
102. Cuscheri A., Hunter J., Wolfe B., et al. Multicenter prospective evaluation of laparoscopic antireflux surgery. Preliminary report. Surg Endosc. 7:1993;505-510.
103. Weerts J.M., Dallemagne B., Harmoir E., et al. Laparoscopic Nissen Fundoplication Detailed analysis of 132 patients . Surg Laparosc Endosc. 3:1993;359-364.
104. Anonymous. Laparoscopic antireflux surgery for gastroesophageal reflux disease. Results of a consensus development conference. Held at the fourth International Congress of the European Association for Endoscopic Surgery. Surg Endosc. 11:1997;413-426.
105. Rattner D.W., Brooks D.C. Patient satisfaction following laparoscopic and open antireflux surgery. Arch Surg. 130:1995;289-293.
106. Richter J.E. Surgery for reflux disease. Reflections of a gastroenterologist. N Engl J Med. 326:1992;825-827.
107. Shirazi S.S., Schulze K., Soper R.T. Long-term follow-up for treatment of complicated chronic reflux esophagitis. Arch Surg. 122:1987;548-552.
108. Luostarinen M., Isolauri J., Laitiner J., et al. Fate of Nissen fundoplication after 20 years. A clinical, endoscopical, and functional analysis. Gut. 34:1993;1015-1020.
109. Brand D.L., Eastwood I.R., Martin D., et al. Esophageal symptoms, manometry and histology before and after antireflux surgery A long-term follow-up study . Gastroenterology. 76:1979;1393-1401.
110. Leite LP, Just RJ, Castell DO, et al. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: Report of two cases. Am J Gastroenterol 195;90:1874-7.
111. Katz P.O., Dalton C.B., Richter J.E., et al. Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients. Ann Intern Med. 106:1987;593-597.
112. Wiener G.J., Koufman J.A., Wu W.C., et al. Chronic hoarseness secondary to gastroesophageal reflux disease Documentation with 24-hr ambulatory Ph monitoring . Am J Gastroenterol. 84:1989;1503-1508.
113. Allen J.C., Newhouse M.T. Gastroesophageal reflux and chronic respiratory disease. Am Rev Resp Dis. 129:1984;645-647.
114. Irwin R.S., French C.L., Curley F.J., et al. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic and pathogenetic aspects. Chest. 194:1993;1511-1517.
115. Ing A.J., Ngu M.C., Breslin A.B.X. Chronic persistent cough and gastro-oesophageal reflux. Thorax. 46:1991;479-483.
116. Clark C.S., Kraus B.B., Sinclair J., et al. Gastroesophageal reflux induced by exercise in healthy volunteers. JAMA. 261:1989;3599-3601.
117. Kraus B.B., Sinclair J.W., Castell D.O. Gastroesophageal reflux in runners. Characteristics and treatment. Ann Intern Med. 112:1990;429-433.
118. Taylor G., Taylor S., Abrams R., et al. Dental erosion associated with asymptomatic gastroesophageal reflux. J Dent Child. 59:1992;182-185.